Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mizuo Miyazaki

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Tissue angiotensin II generating system]Mizuo Miyazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 24, 2004
[Angiotensin II in organ organopathy]Mizuo Miyazaki
Japanese Journal of Pharmacology|December 25, 2002
Effect of chymase inhibitor on vascular proliferationShinji Takai, Mizuo Miyazaki
Drug News & Perspectives|April 5, 2003
The Role of Chymase in Vascular ProliferationShinji Takai, Mizuo Miyazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Anti-atherosclerotic effect]Shinji Takai, Mizuo Miyazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Tumor suppressive effect]Shinji Takai, Mizuo Miyazaki
Journal of Pharmacological Sciences|June 27, 2006
Tissue angiotensin II generating system by angiotensin-converting enzyme and chymaseMizuo Miyazaki, Shinji Takai
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 26, 2002
[Involvement of angiotensin II in development of atherosclerosis]Mizuo Miyazaki, Shinji Takai
Current Vascular Pharmacology|August 24, 2004
A novel therapeutic strategy against vascular disorders with chymase inhibitorShinji Takai, Mizuo Miyazaki
Cardiovascular Drug Reviews|August 22, 2003
Application of a chymase inhibitor, NK3201, for prevention of vascular proliferationShinji Takai, Mizuo Miyazaki
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Tissue angiotensin II generating system]Mizuo Miyazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 24, 2004
[Angiotensin II in organ organopathy]Mizuo Miyazaki
Japanese Journal of Pharmacology|December 25, 2002
Effect of chymase inhibitor on vascular proliferationShinji Takai, Mizuo Miyazaki
Drug News & Perspectives|April 5, 2003
The Role of Chymase in Vascular ProliferationShinji Takai, Mizuo Miyazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Anti-atherosclerotic effect]Shinji Takai, Mizuo Miyazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Tumor suppressive effect]Shinji Takai, Mizuo Miyazaki
Journal of Pharmacological Sciences|June 27, 2006
Tissue angiotensin II generating system by angiotensin-converting enzyme and chymaseMizuo Miyazaki, Shinji Takai
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 26, 2002
[Involvement of angiotensin II in development of atherosclerosis]Mizuo Miyazaki, Shinji Takai
Current Vascular Pharmacology|August 24, 2004
A novel therapeutic strategy against vascular disorders with chymase inhibitorShinji Takai, Mizuo Miyazaki
Cardiovascular Drug Reviews|August 22, 2003
Application of a chymase inhibitor, NK3201, for prevention of vascular proliferationShinji Takai, Mizuo Miyazaki
Pageof 12